Go Pro
→ The retirement stock I'd buy before Nvidia today (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
electroCore, Inc. stock logo
ECOR
electroCore
$10.31
+0.6%		$7.69
$4.41
▼
$10.68
$92.93M0.9288,685 shs38,706 shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.89
-0.4%		$1.16
$0.85
▼
$2.22
$94.60M1.43721,947 shs553,447 shs
LENSAR, Inc. stock logo
LNSR
LENSAR
$8.17
+1.0%		$5.94
$4.95
▼
$12.96
$100.34M0.8998,588 shs207,493 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.68
-0.7%		$0.75
$0.60
▼
$1.69
$25.72M1.2710,795 shs30,922 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
electroCore, Inc. stock logo
ECOR
electroCore
+2.81%+14.40%+74.32%+73.43%+95.61%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
+0.32%-5.71%-3.75%-36.47%-35.55%
LENSAR, Inc. stock logo
LNSR
LENSAR
-1.34%+34.39%+39.48%+39.48%-36.05%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
+0.37%-1.09%-11.19%-14.56%-15.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
electroCore, Inc. stock logo
ECOR
electroCore
$10.31
+0.6%		$7.69
$4.41
▼
$10.68
$92.93M0.9288,685 shs38,706 shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.89
-0.4%		$1.16
$0.85
▼
$2.22
$94.60M1.43721,947 shs553,447 shs
LENSAR, Inc. stock logo
LNSR
LENSAR
$8.17
+1.0%		$5.94
$4.95
▼
$12.96
$100.34M0.8998,588 shs207,493 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.68
-0.7%		$0.75
$0.60
▼
$1.69
$25.72M1.2710,795 shs30,922 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
electroCore, Inc. stock logo
ECOR
electroCore
+2.81%+14.40%+74.32%+73.43%+95.61%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
+0.32%-5.71%-3.75%-36.47%-35.55%
LENSAR, Inc. stock logo
LNSR
LENSAR
-1.34%+34.39%+39.48%+39.48%-36.05%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
+0.37%-1.09%-11.19%-14.56%-15.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
electroCore, Inc. stock logo
ECOR
electroCore
2.00
Hold$18.0074.64% Upside
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.40
Hold$2.03127.95% Upside
LENSAR, Inc. stock logo
LNSR
LENSAR
2.33
Hold$11.0034.64% Upside
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PETV, LNSR, HYPR, and ECOR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$13.00
8/13/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$7.00 ➝ $9.00
8/10/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$2.00 ➝ $1.60
8/7/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
7/17/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
6/24/2026
electroCore, Inc. stock logo
ECOR
electroCore
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
electroCore, Inc. stock logo
ECOR
electroCore
$36.97M2.51N/AN/A($0.21) per share-49.08
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$11.40M8.30N/AN/A$0.42 per share2.12
LENSAR, Inc. stock logo
LNSR
LENSAR
$60.26M1.67N/AN/A($2.18) per share-3.75
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$1.05M24.58N/AN/A($0.03) per share-22.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
electroCore, Inc. stock logo
ECOR
electroCore
-$13.97M-$1.66N/AN/AN/A-39.96%-1,956.38%-81.35%11/4/2026 (Estimated)
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$35.57M-$0.38N/AN/AN/A-210.75%-97.88%-61.81%N/A
LENSAR, Inc. stock logo
LNSR
LENSAR
-$34.28M-$0.33N/AN/AN/A57.57%-529.08%50.03%N/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
-$10.95M-$0.34N/AN/AN/A-902.82%-4,813.07%-281.78%N/A

Latest PETV, LNSR, HYPR, and ECOR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.1650$0.10+$0.2650$0.10$14.65 million$16.50 million
8/6/2026Q2 2026
electroCore, Inc. stock logo
ECOR
electroCore
-$0.4218-$0.33+$0.0918-$0.33$9.49 million$9.45 million
8/6/2026Q2 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.09-$0.09N/A-$0.09$4.14 million$3.90 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
electroCore, Inc. stock logo
ECOR
electroCore
N/A
1.21
1.00
Hyperfine, Inc. stock logo
HYPR
Hyperfine
0.36
6.15
5.45
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
2.39
1.13
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.02
0.42
0.47

Institutional Ownership

CompanyInstitutional Ownership
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
24.55%

Insider Ownership

CompanyInsider Ownership
electroCore, Inc. stock logo
ECOR
electroCore
7.80%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
26.33%
LENSAR, Inc. stock logo
LNSR
LENSAR
65.80%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
10.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
electroCore, Inc. stock logo
ECOR
electroCore
509.02 million8.31 millionNot Optionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
190106.05 million78.13 millionOptionable
LENSAR, Inc. stock logo
LNSR
LENSAR
11012.28 million4.20 millionOptionable
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
2037.95 million19.06 millionNot Optionable

Recent News About These Companies

PetVivo Holdings, Inc.: PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027
August 15 at 9:52 AM  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69320794-petvivo-holdings-inc-petvivo-a-leading-provider-of-veterinary-biomedicals-reports-results-for-fiscal-q1-2027-399.htm
PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript
August 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4936960-petvivo-holdings-inc-petv-q1-2027-earnings-call-transcript
PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027
August 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/14/3345636/0/en/petvivo-a-leading-provider-of-veterinary-biomedicals-reports-results-for-fiscal-q1-2027.html
PetVivo (PETV) Projected to Release Quarterly Earnings on Monday
August 9, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30950799
PetVivo Holdings, Inc.: Petvivo Holdings Announces Termination And Settlement Agreement With Vetstem
July 29, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69151956-petvivo-holdings-inc-petvivo-holdings-announces-termination-and-settlement-agreement-with-vetstem-399.htm
PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM
July 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334842/0/en/petvivo-holdings-announces-termination-and-settlement-agreement-with-vetstem.html
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE TEVA SUMMER CE SYMPOSIUM AT HORSESHOE BAY RESORT, TEXAS
July 21, 2026  |  oklahoman.comO
PetVivo Holdings Inc.
July 20, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/petv/financials/cash-flow
PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record
July 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/14/3326789/0/en/petvivo-holdings-announces-publication-of-peer-reviewed-clinical-study-evaluating-spryng-in-veterinary-record.html
PetVivo Holdings Inc (PETV) Q4 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
July 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/petvivo-holdings-inc-petv-q4-010031330.html
PetVivo Holdings, Inc.: PetVivo Reports Financial and Operational Results for Fiscal 2026
June 30, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-06/68899945-petvivo-holdings-inc-petvivo-reports-financial-and-operational-results-for-fiscal-2026-399.htm
PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript
June 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4918649-petvivo-holdings-inc-petv-q4-2026-earnings-call-prepared-remarks-transcript
PetVivo Reports Financial and Operational Results for Fiscal 2026
June 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/29/3319332/0/en/petvivo-reports-financial-and-operational-results-for-fiscal-2026.html
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
June 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/25/3317927/0/en/petvivo-holdings-inc-to-announce-results-for-the-year-2026-ended-march-31-2026.html
PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform
June 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/24/3316714/0/en/petvivo-holdings-announces-transformative-acquisition-of-piezobiomembrane-to-build-a-leading-functional-biomaterials-platform.html
PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript
June 16, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4915449-petvivo-holdings-inc-petv-discusses-spryng-technology-adoption-and-commercial-expansion-in
PetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24th
June 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/16/3312936/0/en/petvivo-holdings-inc-to-present-at-the-life-sciences-investor-forum-on-june-24th.html
PetVivo Holdings Selects New to The Street for National T.V. Commercials, the #1 New York City Market, Iconic Outdoor Advertising and Influencer Program
June 12, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-06/68731579-petvivo-holdings-selects-new-to-the-street-for-national-t-v-commercials-the-1-new-york-city-market-iconic-outdoor-advertising-and-influencer-progr-200.htm
PetVivo Holdings (OTCQX:PETV) Selects New to The Street for National T.V. Commercials, the #1 New York City Market, Iconic Outdoor Advertising and Influencer Program
June 10, 2026  |  dispatch.comhttps://www.dispatch.com/press-release/story/197426/petvivo-holdings-otcqxpetv-selects-new-to-the-street-for-national-t-v-commercials-the-1-new-york-city-market-iconic-outdoor-advertising-and-influencer-program/
PetVivo Holdings, Inc. to Host Virtual Investor Event
June 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/08/3308411/0/en/petvivo-holdings-inc-to-host-virtual-investor-event.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

electroCore stock logo

electroCore NASDAQ:ECOR

$10.31 +0.06 (+0.56%)
Closing price 03:59 PM Eastern
Extended Trading
$10.48 +0.18 (+1.73%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$0.89 0.00 (-0.42%)
Closing price 03:59 PM Eastern
Extended Trading
$0.90 +0.00 (+0.34%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

LENSAR stock logo

LENSAR NASDAQ:LNSR

$8.17 +0.08 (+0.99%)
Closing price 03:59 PM Eastern
Extended Trading
$8.19 +0.02 (+0.24%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

PetVivo stock logo

PetVivo NASDAQ:PETV

$0.68 0.00 (-0.72%)
As of 01:29 PM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas